Please login to the form below
pulmonary rehabilitation
This page shows the latest pulmonary rehabilitation news and features for those working in and with pharma, biotech and healthcare.
Sharp rise in mobile health app numbers
Released late last year, the work suggests the use of health apps in diabetes prevention, diabetes care, asthma, cardiac rehabilitation and pulmonary rehabilitation could produce significant cost savings.
Latest news
-
Regional NHS pulmonary rehabilitation video campaign launched
A video campaign to promote the health and lifestyle benefits of pulmonary rehabilitation for those with long-term lung conditions has been launched across the north east of England. ... This reported that 90% of people who attend pulmonary
-
Boehringer's Ofev approved by FDA for rare lung disease
The approvals are significant because IPF patients in the US previously had no medicinal alternative to oxygen therapy, pulmonary rehabilitation and lung transplant to treat the condition. ... Dr Badrul Chowdhury, director of the FDA's division of
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
Latest Intelligence
-
GSK forges ahead with its dynamic COPD and asthma portfolio
as Chronic Obstructive Pulmonary Disease (COPD). ... to spirometry, essential medications and pulmonary rehabilitation services.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
A new vision for tackling key illnesses
Pulmonary rehabilitation, which involves activities such as breathing exercises and learning how to cope in an emergency, is one of the most expensive elements of the respiratory pathway.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- Novacyt launches diagnostic test to differentiate between COVID-19 and flu
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- Lilly’s Verzenio scores a win in early-stage breast cancer
- Live Webinar: Leveraging Digital Technologies to Create Valuable KOL Engagements & Empower Patients
- Live Webinar: Harnessing Technology to Improve Health and Healthcare
- Novavax starts first phase 3 COVID-19 vaccine trial in the UK
- Lilly’s Verzenio scores a win in early-stage breast cancer
- FDA sets January decision date for Xalkori in ALK-positive lymphoma
- Q&A: Isabel Gibson
PMHub
Creative Medical Research
Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...
Latest intelligence
- Surviving cancer: a new era for patients
- Now more than ever, a shift in perspective is needed...
- Crisis? No problem!
- Issues planning & management for pharma spokespeople, by Andrew Smith...
- Are patient recruitment and retention rates rising or falling?
- First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Quick links
Infographics
